Key facts
- Notable investors include Antler.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Misala
- ·The full record, as it builds
Funding rounds
No funding rounds for Misala are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Misala
Developer of pharmaceutical products and medical devices designed for women's health. The company aims to redefine wellness with cutting-edge services that challenge conventional approaches, enabling individuals to achieve a state of optimal health and vitality at an affordable price.
- Sector
- Healthcare
- HQ
- Nairobi, Kenya
- Founded
- 2025
- Website
- misalamed.com/
- Ownership
- Privately Held (backing)
Misala doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Misala shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Misala in its N-PORT filings yet. We sweep new filings monthly.